CHM chimeric therapeutics limited

Ann: University of Pennsylvania joins CHM CDH17 Phase 1/2 trial, page-14

  1. 8,333 Posts.
    lightbulb Created with Sketch. 3663
    This is what ChatGPT has to say about the differences between Sarah Cannon and UPenn:-

    The Sarah Cannon Research Institute (SCRI) and University of Pennsylvania (UPenn) are both highly respected in the field of oncology research, but they serve different roles.

    UPenn, particularly with its Perelman School of Medicine, is renowned for pioneering CAR-T technology, with foundational work done by Dr. Carl June and his team.

    SCRI, however, is distinguished for its clinical trials network, offering access to early-phase clinical trials and a large patient base. While it may not be more "advanced" in technology development than UPenn, its strength lies in clinical trial execution.


    The other equally important reason may be to do with IP and our part in developing the technology further. CLTX was also developed in conjunction with Sarah Cannon RI. This from our 2023 Annual Report:-

    https://hotcopper.com.au/data/attachments/6452/6452407-13810efc0b2f6f6a28bee44e3341095f.jpg
    Last edited by Shellbell: 11/09/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $28.14K 7.037M

Buyers (Bids)

No. Vol. Price($)
1 243067 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 15.39pm 20/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.